Daub's group also used stable-isotope labeling, phosphopeptide enrichment and LC-MS ... phosphorylation sites, demonstrating that in–depth coverage could be achieved without applying specific ...

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...

and leading to nerve damage that causes symptoms of MS. An emerging class of drugs, called Bruton's tyrosine kinase (BTK) inhibitors may alter this abnormal B cell respiration and stop the ...